# Senior Director, Global Market Access Launch Strategy Oncology, Targeted Therapies — Bristol Myers Squibb

- Location: Princeton - NJ - US
- Posted pay: $211k–$255k/yr
- Posted: Nov 16, 2026
- Status: open (checked Nov 22, 2026)
- Apply (employer's site): https://bristolmyerssquibb.wd5.myworkdayjobs.com/BMS/job/Princeton---NJ---US/Senior-Director--Global-Market-Access-Launch-Strategy-Oncology--Targeted-Therapies_R1608540-1
- Employer record: https://visajobs.io/company/bristol-myers-squibb.md

## Sponsorship history
- Tier: Employer history only
- With this exact title: 0

## Description
At Bristol Myers Squibb, our employees often ask, “Who are you working for?”—a question that fuels collaboration, accountability, and urgency in our work. Our purpose-driven culture inspires us to discover, develop, and deliver innovative medicines to prevail over serious diseases. We offer uniquely interesting and meaningful work, opportunities for growth, and a supportive environment that values inclusion, wellbeing, flexibility, and comprehensive benefits. This is work that transforms the lives of patients, and the careers of those who do it.
Overview:
The Senior Director, Global Market Access Launch Strategy Oncology, Targeted Therapies, will lead a team focused on developing and executing global market access and pricing strategy for Bristol Myers Squibb Targeted Therapies. The Senior Director will report to Executive Director, Global Market Access Launch Strategy, Oncology and Hematology, and have direct reports with asset/indication responsibilities across Navlimetostat, Krazati, Augtyro, Opdivo, Yervoy, and Atigo covering all relevant indications for these assets. Senior Director may also assume direct asset responsibilities depending on portfolio needs.
The Senior Director will play a critical role in challenging the status quo of traditional pricing and reimbursement approaches and ensure maximization of value recognition across global markets at a time of rapid and intense policy evolution. Thus, we are seeking a strong leader with a proven track record of achieving strong pricing and reimbursement outcomes for global product launches, ability to influence without authority, and demonstrated effectiveness in working within a highly matrixed environment. Further, the Senior Director will contribute substantially to team member development, providing coaching on both technical and non-technical aspects of the role.
This role is highly cross-functional, with collaboration required across multiple teams including, but not limited to Global Commercial, Global MAx, Global Medical, Clinical Development, Regulatory, International Markets, CASA, Product Supply, Global Product Team (GPT) members, Global Pricing, local Market Access and Pricing teams, and Global Policy.
The incumbent will be an agile, proactive and collaborative leader focused on team member development and establishing a high-trust team culture.
Further, as this role will operate in a highly dynamic, quickly evolving, and fast-paced environment, the leader will need to demonstrate ability to effectively manage ambiguity and collaboratively chart a path forward when information is limited. Finally, this leader must demonstrate openness to innovation (including scalable use of AI) and ability to be decisive in deploying resources in a constrained environment.
Responsibilities:
Lead the team in preparing for and executing key processes to ensure that Access insights are embedded into cross-functional Commercial and Clinical decision making, particularly at key governance milestones Input into Phase 3 trial design and preparation for trial Go/No-Go decisions (ie, DEX, LTFP pricing sign off, ID4 CDOC meeting)
Preparation for launch readiness activities (ie, launch sequencing strategy, value message creation and testing, development and delivery of Integrated Access Strategy, JCA strategy preparation and execution, market workshops)
Post-approval market support (ie, assist markets with P&R dossiers, advise on market specific price exceptions/business cases)
Actively engage with access colleagues in key markets and contribute to educational and strategy sessions for markets, including New Product Planning meetings, monthly virtual MAx Forum meetings, and Regional MAx Forums
Build relationships with Global colleagues and In-Market Access colleagues and serve as strategic bridge between market needs and global considerations
In partnership with Access Strategy Integration team, ensure assumptions in the Long Term Financial Plan and Budget Reviews are accurate and updated as needed
Work closely with International Markets Access team, to support asset strategy upskilling and pressure test value asset-level optimization strategies and explore innovative solutions
Identify current and emerging payer, policy, and health authority trends in key markets (e.g. MFN and IRA in the US, JCA in the EU etc), assess implications, educate cross-functional stakeholders, and plan mitigations
Oversee team in pursuing new processes such as JCA readiness and ensuring coordination with key internal stakeholders
Provide support and coaching to ensure team development, upskilling, and retention
Champion utilization of AI to achieve high-quality objectives in an increasingly scalable manner and share learnings with broader team for broader team upskilling
Leadership Capabilities:
Enterprise Mindset Uses knowledge of external and internal business factors to inform decisions
Ensures teams are responsible for contributing beyond their own function
Proactively connects teams, networks and individuals in order to increase organizational performance
Creates integrated, long term strategies that have the potential to transform BMS and the industry
Authentic Leadership Fosters a climate of self-awareness and open dialogue; speaks to personal struggles and how they deal with/overcome them
Understands others’ styles and approaches and knows how to leverage and value them
Holds others accountable for doing the right thing, even when it requires some personal risk
Change Agility Identifies and creates distinctive, game-changing opportunities that lead to higher organizational performance
Has the data and rationale to see the future of the industry, frames it in an understandable way and wins support for change in a fast-paced environment
Thinks 3-5 years ahead, develops contingency plans for multiple scenarios
Hires, develops and rewards change agents, welcoming and encouraging those who challenge, to the status quo and test their own thinking
Talent Developer
Use

> History, not a promise: past H-1B filings do not mean an employer will sponsor you or a given role. Data: U.S. DOL OFLC LCA disclosure (FY2024–FY2026 for role counts, certified LCAs) and the USCIS H-1B Employer Data Hub. Not legal advice. Methodology: https://visajobs.io/methodology
